Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
18%
OVERLAP
BY WEIGHT
34
# OF OVERLAPPING
HOLDINGS
IBBQ
208
HOLDINGS
16%
ALSO IN CANC
CANC
50
HOLDINGS
68%
ALSO IN IBBQ
SECTOR DRIFT (IBBQ minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBBQ |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 7.2% | 2.3% | 2.3% |
|
SUMMIT THERAPEUTICS INC | 2.0% | 3.1% | 2.0% |
|
GILEAD SCIENCES INC | 7.5% | 1.9% | 1.9% |
 |
ARGENX SE ADR | 2.1% | 1.8% | 1.8% |
|
REGENERON PHARMACEUTICALS | 6.2% | 1.4% | 1.4% |
IBBQ Overweight Relative to CANC
|
VERTEX PHARMACEUTICALS INC | 6.2% |
|
GILEAD SCIENCES INC | 5.6% |
|
ALNYLAM PHARMACEUTICALS INC | 5.2% |
|
AMGEN INC | 4.9% |
|
REGENERON PHARMACEUTICALS | 4.8% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.7% |
|
INSMED INC | 2.4% |
|
BIOGEN IDEC INC | 2.1% |
|
INCYTE CORP | 1.7% |
|
ROYALTY PHARMA PLC CLASS A | 1.6% |
IBBQ Underweight Relative to CANC
 |
ROCHE HOLDINGS LTD-SPONS ADR | -4.9% |
|
REVOLUTION MEDICINES, INC. | -4.6% |
|
NOVARTIS AG | -4.6% |
|
ASTRAZENECA PLC | -4.4% |
|
BRIDGEBIO PHARMA, INC. | -4.1% |
 |
GENMAB A/S SPONSORED ADR | -4.0% |
 |
MERUS N.V. | -4.0% |
|
ELI LILLY & CO | -3.8% |
|
BRISTOL-MYERS SQUIBB CO | -3.1% |
|
ABBVIE INC | -2.9% |